These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8976875

  • 1. Expression of cripto in human gall bladder lesions.
    Fujii K, Yasui W, Kuniyasu H, Itoh M, Hanada K, Kajiyama G, Tahara E.
    J Pathol; 1996 Oct; 180(2):166-8. PubMed ID: 8976875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
    Saeki T, Stromberg K, Qi CF, Gullick WJ, Tahara E, Normanno N, Ciardiello F, Kenney N, Johnson GR, Salomon DS.
    Cancer Res; 1992 Jun 15; 52(12):3467-73. PubMed ID: 1596904
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The immunohistochemical detection of cripto-1 in benign and malignant human bladder.
    Byrne RL, Autzen P, Birch P, Robinson MC, Gullick WJ, Neal DE, Hamdy FC.
    J Pathol; 1998 May 15; 185(1):108-11. PubMed ID: 9713367
    [Abstract] [Full Text] [Related]

  • 6. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 15; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 7. Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas.
    Hong SP, Lee EK, Park JY, Jeon TJ, Bang S, Park S, Chung JB, Lee WJ, Kim H, Song SY.
    Oncol Rep; 2009 Jan 15; 21(1):19-24. PubMed ID: 19082438
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K, Dobashi Y, Suzuki S, Fujii H, Takeda Y, Ooi A.
    J Pathol; 2005 Jul 15; 206(3):356-65. PubMed ID: 15892172
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of AgNORs in diagnosis of early malignant lesions of gall bladder.
    Misra V, Misra SP, Dwivedi M, Gupta SC.
    Indian J Pathol Microbiol; 1995 Oct 15; 38(4):383-8. PubMed ID: 9726148
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder.
    Shu GS, Yang LP, Yang ZL, Jiang S.
    Cancer Biomark; 2012 Oct 15; 11(2-3):107-14. PubMed ID: 23011157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.